New On The Block
Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, announced that, after extensive consideration of the company's pipeline and financial resources, it has retained Raymond James as its financial advisor to assist in evaluating a full range of strategic alternatives to "advance its promising pipeline" and to maximize value for all stakeholders, the company said in a press release.
Zooz Strategy (NASDAQ:ZOOZ) is exploring a range of strategic alternatives that could potentially complement the Company's existing bitcoin treasury strategy and enhance long-term shareholder value. The review and evaluation of strategic alternatives may include, among other things, potential business combinations, acquisitions, strategic investments, operating businesses, partnerships, joint ventures, capital markets initiatives, and other corporate transactions.
Read Next
Private Markets
